Product Information

METOPROLOL SUCC ER 200 MG TAB is a generic product labeled by Oryza Pharmaceuticals Inc., priced at $0.1903 per EA under NDC 72516003301. Its NADAC has been published 218 times since Sep 21, 2022.

FDA first approved this application on Dec 19, 2018. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

METOPROLOL SUCC ER 200 MG TAB

Metoprolol Succinate
$0.1903per EA

Strength

200 mg/1

NDC

72516003301

Classification

Generic

Dosage Form

TABLET, EXTENDED RELEASE

Route

ORAL

Effective Date

11/18/2026

Active Ingredients

METOPROLOL TARTRATE

Approval Type

Generic (ANDA)

FDA Application

ANDA207206

FDA Approved

12/19/2018

TE Code

AB

On Market Since

4/27/2022

Pharmacological Classes

Adrenergic beta-Antagonists
beta-Adrenergic Blocker

Price Statistics

The NADAC for METOPROLOL SUCC ER 200 MG TAB has been published 218 times since Sep 21, 2022, and over the history we have for it it has declined 34.8%. The table below summarizes its recorded NADAC range and movement.

Current price$0.1903 per EA
All-time high$0.2917 (Oct 12, 2022)
All-time low$0.1284 (Nov 20, 2024)
52-week high$0.1997
52-week low$0.1714
Median price$0.1851
Average price$0.1896
Largest weekly change+48.9% (Aug 23, 2023)
Weeks tracked218
Tracking sinceSep 21, 2022

Price History

1W

+5.4%

1M

+1.2%

3M

+1.8%

6M

+9.7%

1Y

+6.4%

3Y

+8.8%

5Y

N/A

All

-34.8%

Generic Alternatives

The matcher finds 5 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 12% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of METOPROLOL SUCC ER 200 MG TAB?

The current National Average Drug Acquisition Cost (NADAC) for METOPROLOL SUCC ER 200 MG TAB, manufactured by Oryza Pharmaceuticals Inc., is $0.1903 per EA (NDC 72516003301), effective Nov 18, 2026.

How has the price of METOPROLOL SUCC ER 200 MG TAB changed over time?

Over the history we have for it, the NADAC for METOPROLOL SUCC ER 200 MG TAB has declined 34.8%. It has been tracked across 218 weekly CMS publications since Sep 21, 2022.

What are the highest and lowest recorded NADAC prices for METOPROLOL SUCC ER 200 MG TAB?

Since Sep 21, 2022, the NADAC for METOPROLOL SUCC ER 200 MG TAB has ranged from a low of $0.1284 (Nov 20, 2024) to a high of $0.2917 (Oct 12, 2022), with a median of $0.1851 per EA.

Are there cheaper alternatives to METOPROLOL SUCC ER 200 MG TAB?

Yes. 5 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, METOPROLOL SUCC ER 200 MG TAB, is $0.1678 per EA — about 12% below METOPROLOL SUCC ER 200 MG TAB.

Who manufactures METOPROLOL SUCC ER 200 MG TAB?

METOPROLOL SUCC ER 200 MG TAB (NDC 72516003301) is labeled by Oryza Pharmaceuticals Inc., and CMS classifies it as a generic product.